Found: 9
Select item for more details and to access through your institution.
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 2139, doi. 10.1007/s00432-022-04247-z
- By:
- Publication type:
- Article
The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 6, p. 1, doi. 10.1007/s00403-024-03108-8
- By:
- Publication type:
- Article
Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus‐14 and ‐21.
- Published in:
- Journal of Cutaneous Pathology, 2023, v. 50, n. 1, p. 47, doi. 10.1111/cup.14319
- By:
- Publication type:
- Article
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49.
- Published in:
- Journal of Cutaneous Pathology, 2022, v. 49, n. 7, p. 658, doi. 10.1111/cup.14221
- By:
- Publication type:
- Article
Trichodysplasia spinulosa polyomavirus small T antigen synergistically modulates S6 protein translation and DNA damage response pathways to shape host cell environment.
- Published in:
- Virus Genes, 2022, v. 58, n. 1, p. 35, doi. 10.1007/s11262-021-01880-7
- By:
- Publication type:
- Article
Current treatments and emerging therapies of human polyomavirus‐associated skin diseases: a comprehensive review.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. 387, doi. 10.1111/ijd.16534
- By:
- Publication type:
- Article
Molecular evidence for selinexor as a treatment for Merkel cell polyomavirus (MCPyV)‐positive Merkel cell carcinoma.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 2, p. e68, doi. 10.1111/ijd.16057
- By:
- Publication type:
- Article
Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 8, p. 903, doi. 10.1093/ced/llad081
- By:
- Publication type:
- Article
Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 7, p. 1354, doi. 10.1111/ced.15120
- By:
- Publication type:
- Article